申请人:CADILA HEALTHCARE LIMITED
公开号:EP1927589A1
公开(公告)日:2008-06-04
The present invention relates to novel compounds of general formula (I), their tautomeric forms, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to a process for preparing compounds of general formula (I), their tautomeric forms, their pharmaceutically acceptable salts and pharmaceutical compositions containing them.
本发明涉及一般式(I)的新化合物,它们的互变异构形式,它们的药学上可接受的盐以及含有它们的药物组合物。本发明还涉及一种制备一般式(I)化合物、它们的互变异构形式、药学上可接受的盐以及含有它们的药物组合物的方法。